Home > > > Report Detail

Global Non-oncology Biopharmaceuticals Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 24-Jun-2019
No. of pages: 138

Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.

Scope of the Report:

The global Non-oncology Biopharmaceuticals market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-oncology Biopharmaceuticals.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Non-oncology Biopharmaceuticals market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-oncology Biopharmaceuticals market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Roche

- Sanofi

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Novartis

- Merck

- Teva

- Eli Lilly

- Bristol-Myers Squibb

- GlaxoSmithKline

- UCB Pharma

- Amgen

- AbbVie

- Takeda

- AstraZeneca

- Mylan

- LEO Pharma

- Boehringer Ingelheim

- Alexion Pharmaceuticals

- Elusys Therapeutics

- Swedish Orphan Biovitrum

- Biogen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Biologics

- Biosimilars

Market Segment by Applications, can be divided into

- Immunology

- Endocrinology

- Others

Global Non-oncology Biopharmaceuticals Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Non-oncology Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals
1.2 Classification of Non-oncology Biopharmaceuticals by Types
1.2.1 Global Non-oncology Biopharmaceuticals Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018
1.2.3 Biologics
1.2.4 Biosimilars
1.3 Global Non-oncology Biopharmaceuticals Market by Application
1.3.1 Global Non-oncology Biopharmaceuticals Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Immunology
1.3.3 Endocrinology
1.3.4 Others
1.4 Global Non-oncology Biopharmaceuticals Market by Regions
1.4.1 Global Non-oncology Biopharmaceuticals Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.5 Global Market Size of Non-oncology Biopharmaceuticals (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Non-oncology Biopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Non-oncology Biopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Non-oncology Biopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novo Nordisk
2.5.1 Business Overview
2.5.2 Non-oncology Biopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Non-oncology Biopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Non-oncology Biopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva
2.8.1 Business Overview
2.8.2 Non-oncology Biopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Non-oncology Biopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Non-oncology Biopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Non-oncology Biopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.12 UCB Pharma
2.12.1 Business Overview
2.12.2 Non-oncology Biopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.13 Amgen
2.13.1 Business Overview
2.13.2 Non-oncology Biopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.14 AbbVie
2.14.1 Business Overview
2.14.2 Non-oncology Biopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.15 Takeda
2.15.1 Business Overview
2.15.2 Non-oncology Biopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.16 AstraZeneca
2.16.1 Business Overview
2.16.2 Non-oncology Biopharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.17 Mylan
2.17.1 Business Overview
2.17.2 Non-oncology Biopharmaceuticals Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.18 LEO Pharma
2.18.1 Business Overview
2.18.2 Non-oncology Biopharmaceuticals Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.19 Boehringer Ingelheim
2.19.1 Business Overview
2.19.2 Non-oncology Biopharmaceuticals Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.20 Alexion Pharmaceuticals
2.20.1 Business Overview
2.20.2 Non-oncology Biopharmaceuticals Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.21 Elusys Therapeutics
2.21.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.22 Swedish Orphan Biovitrum
2.22.1 Business Overview
2.22.2 Non-oncology Biopharmaceuticals Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.23 Biogen
2.23.1 Business Overview
2.23.2 Non-oncology Biopharmaceuticals Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-oncology Biopharmaceuticals Market Competition, by Players
3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-oncology Biopharmaceuticals Players Market Share
3.2.2 Top 10 Non-oncology Biopharmaceuticals Players Market Share
3.3 Market Competition Trend
4 Global Non-oncology Biopharmaceuticals Market Size by Regions
4.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Regions
4.2 North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.3 Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.5 South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5 North America Non-oncology Biopharmaceuticals Revenue by Countries
5.1 North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
5.2 USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.3 Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6 Europe Non-oncology Biopharmaceuticals Revenue by Countries
6.1 Europe Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
6.2 Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.3 UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.4 France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.5 Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.6 Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries
7.1 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
7.2 China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.3 Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.4 Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.5 India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8 South America Non-oncology Biopharmaceuticals Revenue by Countries
8.1 South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
8.2 Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-oncology Biopharmaceuticals by Countries
9.1 Middle East and Africa Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.3 UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
10 Global Non-oncology Biopharmaceuticals Market Segment by Type
10.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2019-2024)
10.3 Biologics Revenue Growth Rate (2014-2024)
10.4 Biosimilars Revenue Growth Rate (2014-2024)
11 Global Non-oncology Biopharmaceuticals Market Segment by Application
11.1 Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2014-2019)
11.2 Non-oncology Biopharmaceuticals Market Forecast by Application (2019-2024)
11.3 Immunology Revenue Growth (2014-2019)
11.4 Endocrinology Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024)
12.1 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Regions (2019-2024)
12.3 North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.4 Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.6 South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Non-oncology Biopharmaceuticals Picture
Table Product Specifications of Non-oncology Biopharmaceuticals
Table Global Non-oncology Biopharmaceuticals and Revenue (Million USD) Market Split by Product Type
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018
Figure Biologics Picture
Figure Biosimilars Picture
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Application (2014-2024)
Figure Non-oncology Biopharmaceuticals Revenue Market Share by Applications in 2018
Figure Immunology Picture
Figure Endocrinology Picture
Figure Others Picture
Table Global Market Non-oncology Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Non-oncology Biopharmaceuticals Type and Applications
Table Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Non-oncology Biopharmaceuticals Type and Applications
Table Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Non-oncology Biopharmaceuticals Type and Applications
Table Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Non-oncology Biopharmaceuticals Type and Applications
Table Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Non-oncology Biopharmaceuticals Type and Applications
Table Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Non-oncology Biopharmaceuticals Type and Applications
Table Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Non-oncology Biopharmaceuticals Type and Applications
Table Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Non-oncology Biopharmaceuticals Type and Applications
Table Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Non-oncology Biopharmaceuticals Type and Applications
Table Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Type and Applications
Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Non-oncology Biopharmaceuticals Type and Applications
Table GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table UCB Pharma Basic Information, Manufacturing Base and Competitors
Table UCB Pharma Non-oncology Biopharmaceuticals Type and Applications
Table UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Non-oncology Biopharmaceuticals Type and Applications
Table Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Non-oncology Biopharmaceuticals Type and Applications
Table AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Non-oncology Biopharmaceuticals Type and Applications
Table Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Non-oncology Biopharmaceuticals Type and Applications
Table AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Non-oncology Biopharmaceuticals Type and Applications
Table Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Non-oncology Biopharmaceuticals Type and Applications
Table LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Type and Applications
Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Type and Applications
Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Elusys Therapeutics Basic Information, Manufacturing Base and Competitors
Table Elusys Therapeutics Non-oncology Biopharmaceuticals Type and Applications
Table Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors
Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Type and Applications
Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Non-oncology Biopharmaceuticals Type and Applications
Table Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Players (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Players (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2017
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2018
Figure Global Top 5 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018
Figure Global Top 10 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Regions (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions in 2018
Figure North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
Table North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Europe Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
Table South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Type (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type in 2018
Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Type (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2019-2024)
Figure Global Biologics Revenue Growth Rate (2014-2019)
Figure Global Biosimilars Revenue Growth Rate (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue by Application (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application in 2018
Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Application (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2019-2024)
Figure Global Immunology Revenue Growth Rate (2014-2019)
Figure Global Endocrinology Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs